SCHEMBL5654798

SCHEMBL5654798

COc1ccc(C2=CC(COC(=O)c3cc(Br)c(Br)s3)OC2=O)cc1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
MAPT P10636 6/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
PKM P14618 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5655644 0.86 L3MBTL1 (0.42) MEN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5655483 0.84 CSNK2A2 (0.36) MEN1MAPTKMT2APOLBPKM
SCHEMBL5652657 0.84 CSNK2A2 (0.37) MEN1MAPTKMT2APOLBPKM
SCHEMBL5652451 0.84 CYP1A2 (0.44) MEN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5655594 0.84 ALDH1A1 (0.38) MEN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14392850 0.83 HDAC3 (0.35) MEN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5654011 0.82 CSNK2A2 (0.36) MEN1MAPTKMT2APOLBPKM
SCHEMBL5653037 0.82 MEN1 (0.36) MEN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5655645 0.80 CYP1A2 (0.36) MEN1HDAC3HDAC4HDAC1HDAC7
SCHEMBL5655613 0.79 MAPT (0.35) MEN1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed
US-20070259948-A1 Compounds with antifungal properties and process thereof FDC LIMITED (IN) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259948-A1 Compounds with antifungal properties and process thereof ADH5, GK, AKR1C3 MEN1 2702/4885HDAC3 559/4885HDAC4 1260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.